The University of Chicago Header Logo

Connection

Vesselin Dimov to Anti-Asthmatic Agents

Back to Details
This is a "connection" page, showing publications Vesselin Dimov has written about Anti-Asthmatic Agents.
Vesselin Dimov
Connection Strength
0.505
Anti-Asthmatic Agents
  1. Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults. Expert Opin Drug Metab Toxicol. 2017 Dec; 13(12):1275-1280.
    View in: PubMed
    Score: 0.505
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.